Carnival is a Buy and 2 More Analyst Notes to Read

Biolase (NASDAQ:BIOL): Northland Capital reiterated its rating of Outperform for this company and changed its price target from $6 to $7.

Dow 15,000? S&P 1,600? Searching for market direction? Reduce the information clutter and uncover key insights and investment ideas. Click here to for Your Stock Investor Cheat Sheet Now!

BIOL

More Articles About:   , , ,